Navigation Links
Blood Test May Catch Deadly Fungal Infection Quickly
Date:4/24/2013

By Amy Norton
HealthDay Reporter

WEDNESDAY, April 24 (HealthDay News) -- An experimental test could help doctors catch a deadly type of fungal infection in the blood within a few hours, rather than the few days it currently takes, a new study suggests.

The test, which is not yet on the market, looks for Candida infection in the blood. The fungus is best known for causing common vaginal yeast infections, but when it gets into the bloodstream it can cause serious infections of organs and tissue throughout the body.

Candida blood infections -- known as candidemia -- are very rare in healthy people, but they are the fourth most common type of blood infection among U.S. hospital patients, according to the U.S. Centers for Disease Control and Prevention.

The infection is typically transmitted through contaminated catheters, and seen in seriously ill patients -- such as those in the intensive care unit, or with weakened immune systems.

The symptoms of candidemia are vague, and include fever and chills, so doctors use blood cultures to diagnose it. That means putting a blood sample in a special broth that feeds the yeast organism until it grows enough to be detected.

But Candida "is a slow grower," and it takes a few days to get blood culture results back, said Thomas Lowery of T2 Biosystems, the Lexington, Mass.-based company developing the new test.

By that time, it may be too late for the patient. About 40 percent of people with Candida blood infections die, and delayed diagnosis bears part of the blame, Lowery and his colleagues write in the April 24 issue of the journal Science Translational Medicine.

Getting a precise diagnosis is vital, Lowery said, both to confirm that it's Candida, and to pinpoint which type it is. "You need to know the specific Candida so you can use the right antifungal drug," he said.

In the new study, Lowery's team found that the test they've developed can reliably detect the five most common species of Candida within about three hours.

The researchers used blood samples from healthy people and "spiked" them with Candida yeast. They then analyzed the samples with the new test and with standard blood cultures. The two tests were in agreement on "positives" 98 percent of the time.

An expert not involved in the research said the test's sensitivity is "very, very good."

"This is preliminary, but the technology looks extremely promising," said Christine Ginocchio, chief of infectious disease diagnostics at North Shore-LIJ Health System in Lake Success, N.Y.

What's particularly "exciting" is that the technology could potentially be used to test for other pathogens that cause serious bloodstream infections, according to Ginocchio, who is also a member of the Infectious Diseases Society of America's Diagnostics Task Force.

Ideally, Ginocchio explained, when doctors suspect a patient has a bloodstream infection, they would be able to take a blood sample, directly test it, then have a result in a few hours. The problem right now is that a blood sample would normally not contain enough of the culprit bug -- be it a fungus or bacterium -- to detect.

Plus, Ginocchio noted, the blood contains a lot of other genetic material that gets in the way of spotting that bit of foreign-invader DNA. That's why blood cultures are done.

The new test, which is based on so-called magnetic resonance technology, essentially removes the "noise" coming from other material in the blood sample, allowing it to zero in on the pathogen.

There is still more work to be done. "Now you'd like to see this tested in a larger, multicenter trial," Ginocchio said.

The process would also need to be automated, she noted, to be feasible for smaller community hospitals. T2 Biosystems' Lowery said the researchers are working on making the method "fully automated."

Exactly what it would all cost is not known. But both Ginocchio and Lowery said that if the test gets more patients on the right drug quickly, the cost would likely be worth it.

According to Lowery's team, research suggests that with Candida infections, starting the right antifungal drug within 12 hours can cut the death rate from 40 percent to 11 percent.

More information

Learn more about Candida blood infections from the U.S. Centers for Disease Control and Prevention.

SOURCES: Thomas Lowery, Ph.D., vice president, diagnostics research and development, T2 Biosystems, Lexington, Mass; Christine Ginocchio, Ph.D., chief, infectious disease diagnostics, North Shore-LIJ Health Systems Laboratories, Lake Success, N.Y.; April 24, 2013, Science Translational Medicine, online


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Off-the-Shelf Artificial Blood Vessels Show Promise
2. Exercise, Alternative Therapies May Help Lower Blood Pressure
3. Metastasis stem cells in the blood of breast cancer patients discovered
4. Tekturna Infographic Released by d’Oliveira & Associates Imparts Potential Side Effects of Blood Pressure Drug
5. Blood pressure out of control at safety-net clinics
6. Rockford Ravens Rugby Football Club to Host Blood Drive with Rock River Valley Blood Center
7. Increased risk of cardiovascular disease for pregnant women with high blood pressure
8. 2013 NuvaRing Blood-Clotting Allegations Inquiries Eligible for Review by Resource4thePeople Attorneys
9. Blood Drive at Crimson Pointe Assisted Living Facility with Rock River Valley Blood Center
10. Could Coffee Bean Extract Help Control Blood Sugar?
11. Blood tests can provide fuller picture of mutations in cancer than traditional biopsies do
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Test May Catch Deadly Fungal Infection Quickly
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations ... literacy software tool, and the Cancer Patient Education Network (CPEN), an independent professional ... announce a new strategic alliance. , As CPEN’s strategic partner, HLI will ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... Divoti USA will engrave and process all non-coated ... latest FDA requirements, which stipulates new criteria regarding medical device manufacture ... Medical ID jewelry such as Medical ID Bracelets, can rest assured ... of the new FDA requirements . ... Divoti offers this dark mark fiber laser engraving process ...
(Date:10/11/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX) researchers were ... innovative way to use nonlinear optical imaging to confirm ... drugs. A ... show how researchers from BioPharmX and the Wellman Center ... a suite of imaging techniques in what is called ...
(Date:10/11/2017)...  True Health, a leader in integrated diagnostics ... National Breast Cancer Awareness month to educate doctors ... Research recently published in ... than 10 million American women are at significant ... BRCA2 and have not had testing. These mutations can ...
Breaking Medicine Technology: